Morgan Stanley Evogene Ltd. Transaction History

Morgan Stanley

  • $1.35 Trillion
  • Q3 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Oct 17, 2024
SELL
$0.61 - $0.82 $40,011 - $53,786
-65,593 Reduced 23.09%
218,455 $141,000
Q2 2024

Aug 14, 2024
SELL
$0.61 - $0.82 $40,011 - $53,786
-65,593 Reduced 23.09%
218,455 $141,000
Q1 2024

Oct 17, 2024
BUY
$0.7 - $0.98 $45,915 - $64,281
65,593 Added 30.03%
284,048 $213,000
Q1 2024

Aug 16, 2024
BUY
$0.7 - $0.98 $66,921 - $93,689
95,602 Added 50.73%
284,048 $213,000
Q1 2024

May 15, 2024
BUY
$0.7 - $0.98 $66,921 - $93,689
95,602 Added 50.73%
284,048 $213,000
Q4 2023

Aug 16, 2024
SELL
$0.47 - $0.88 $14,104 - $26,407
-30,009 Reduced 13.74%
188,446 $158,000
Q4 2023

Feb 13, 2024
BUY
$0.47 - $0.88 $5,936 - $11,115
12,631 Added 7.18%
188,446 $158,000
Q3 2023

Nov 15, 2023
BUY
$0.58 - $1.41 $28,429 - $69,112
49,016 Added 38.66%
175,815 $103,000
Q2 2023

Aug 14, 2023
SELL
$0.56 - $1.2 $25,579 - $54,813
-45,678 Reduced 26.48%
126,799 $135,000
Q1 2023

May 15, 2023
SELL
$0.59 - $0.86 $39,491 - $57,564
-66,935 Reduced 27.96%
172,477 $108,000
Q4 2022

Feb 14, 2023
BUY
$0.61 - $8.13 $3,481 - $46,397
5,707 Added 2.44%
239,412 $167,000
Q3 2022

Nov 14, 2022
BUY
$0.73 - $8.65 $26,689 - $316,252
36,561 Added 18.55%
233,705 $194,000
Q2 2022

Oct 27, 2022
SELL
$0.75 - $1.33 $78,644 - $139,462
-104,859 Reduced 34.72%
197,144 $151,000
Q2 2022

Aug 15, 2022
SELL
$0.75 - $1.33 $78,644 - $139,462
-104,859 Reduced 34.72%
197,144 $151,000
Q1 2022

Oct 27, 2022
BUY
$1.09 - $1.83 $114,296 - $191,891
104,859 Added 53.19%
302,003 $393,000
Q1 2022

May 13, 2022
BUY
$1.09 - $1.83 $40,713 - $68,354
37,352 Added 14.11%
302,003 $393,000
Q4 2021

Feb 14, 2022
SELL
$1.63 - $2.83 $313,895 - $544,984
-192,574 Reduced 42.12%
264,651 $434,000
Q3 2021

Nov 15, 2021
BUY
$2.45 - $3.45 $1.12 Million - $1.58 Million
457,225 New
457,225 $1.21 Million

Others Institutions Holding EVGN

# of Institutions
1
Shares Held
117K
Call Options Held
0
Put Options Held
0
View Full List

About Evogene Ltd.

EVGN Quotes by TradingView
  • Ticker EVGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,202,000
  • Market Cap $61.4M
  • Description
  • Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...
More about EVGN
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email